Hafrun Fridriksdottir Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Hafrun Fridriksdottir.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Hafrun Fridriksdottir. Hafrun Fridriksdottir is Executive VP, Global R&D in TEVA PHARMACEUTICAL INDUSTRIES LTD ($TEVA) and Sr VP,Global Generics R&D in Actavis, Inc. ($ACT).
Latest Insider Trading Transactions of Hafrun Fridriksdottir
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2021 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 37,884 | 0 | 0 | |
May 13 2021 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 10.22 | 19,066 | 194,830 | 92,272 | 111.3 K to 92.3 K (-17.12 %) |
May 13 2021 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 37,884 | 0 | 111,338 | 73.5 K to 111.3 K (+51.58 %) |
Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | A | 0.00 | 95,057 | 0 | 95,057 | |
Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 18,905 | 0 | 37,811 | |
Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 10.57 | 9,515 | 100,536 | 73,454 | 83 K to 73.5 K (-11.47 %) |
Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 18,905 | 0 | 82,969 | 64.1 K to 83 K (+29.51 %) |
Mar 04 2021 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 10.82 | 50,000 | 540,890 | 64,064 | 114.1 K to 64.1 K (-43.84 %) |
Feb 17 2021 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 5,355 | 0 | 0 | |
Feb 17 2021 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 11.12 | 2,098 | 23,336 | 103,294 | 105.4 K to 103.3 K (-1.99 %) |
Feb 17 2021 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 5,355 | 0 | 105,392 | 100 K to 105.4 K (+5.35 %) |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 266 | 0 | 0 | |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 748 | 0 | 0 | |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 7.16 | 134 | 960 | 45,561 | 45.7 K to 45.6 K (-0.29 %) |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 7.16 | 380 | 2,722 | 45,695 | 46.1 K to 45.7 K (-0.82 %) |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 266 | 0 | 46,075 | 45.8 K to 46.1 K (+0.58 %) |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 748 | 0 | 45,809 | 45.1 K to 45.8 K (+1.66 %) |
Mar 03 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | A | 0.00 | 86,730 | 0 | 86,730 | |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 17,850 | 0 | 0 | |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 5,353 | 0 | 5,355 | |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 12.14 | 8,825 | 107,155 | 45,061 | 53.9 K to 45.1 K (-16.38 %) |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 12.14 | 2,647 | 32,140 | 53,886 | 56.5 K to 53.9 K (-4.68 %) |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 17,850 | 0 | 56,533 | 38.7 K to 56.5 K (+46.14 %) |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 5,353 | 0 | 38,683 | 33.3 K to 38.7 K (+16.06 %) |
Feb 13 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | A | 0.00 | 17,850 | 0 | 17,850 | |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 16,120 | 0 | 32,241 | |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 12.27 | 5,544 | 68,025 | 33,330 | 38.9 K to 33.3 K (-14.26 %) |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 16,120 | 0 | 38,874 | 22.8 K to 38.9 K (+70.84 %) |
Jan 02 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 4,640 | 0 | 0 | |
Jan 02 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 9.92 | 2,459 | 24,396 | 22,754 | 25.2 K to 22.8 K (-9.75 %) |
Jan 02 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 4,640 | 0 | 25,213 | 20.6 K to 25.2 K (+22.55 %) |
Dec 03 2019 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 8,133 | 0 | 0 | |
Dec 03 2019 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 10.49 | 4,310 | 45,214 | 20,573 | 24.9 K to 20.6 K (-17.32 %) |
Dec 03 2019 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 8,133 | 0 | 24,883 | 16.8 K to 24.9 K (+48.56 %) |
Mar 19 2019 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 265 | 0 | 266 | |
Mar 19 2019 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 747 | 0 | 748 | |
Mar 19 2019 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 16.63 | 93 | 1,546 | 16,750 | 16.8 K to 16.8 K (-0.55 %) |
Mar 19 2019 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 16.63 | 263 | 4,372 | 16,843 | 17.1 K to 16.8 K (-1.54 %) |
Mar 19 2019 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 265 | 0 | 17,106 | 16.8 K to 17.1 K (+1.57 %) |
Mar 19 2019 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 747 | 0 | 16,841 | 16.1 K to 16.8 K (+4.64 %) |
Mar 06 2019 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | A | 0.00 | 56,716 | 0 | 56,716 | |
Mar 05 2019 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 1,165 | 0 | 0 | |
Mar 05 2019 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 16.88 | 409 | 6,905 | 16,094 | 16.5 K to 16.1 K (-2.48 %) |
Mar 05 2019 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 1,165 | 0 | 16,503 | 15.3 K to 16.5 K (+7.60 %) |
Feb 19 2019 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 5,353 | 0 | 10,708 | |
Feb 19 2019 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 17.67 | 1,841 | 32,529 | 15,338 | 17.2 K to 15.3 K (-10.72 %) |
Feb 19 2019 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 5,353 | 0 | 17,179 | 11.8 K to 17.2 K (+45.26 %) |
Jan 03 2019 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 4,640 | 0 | 4,640 | |
Jan 03 2019 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 15.70 | 1,643 | 25,799 | 11,826 | 13.5 K to 11.8 K (-12.20 %) |
Jan 03 2019 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 4,640 | 0 | 13,469 | 8.8 K to 13.5 K (+52.55 %) |
Dec 04 2018 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 2,711 | 0 | 8,133 | |
Dec 04 2018 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 21.76 | 933 | 20,304 | 8,829 | 9.8 K to 8.8 K (-9.56 %) |
Dec 04 2018 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 2,711 | 0 | 9,762 | 7.1 K to 9.8 K (+38.45 %) |
Mar 20 2018 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 265 | 0 | 531 | |
Mar 20 2018 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 747 | 0 | 1,495 | |
Mar 20 2018 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 17.88 | 91 | 1,627 | 7,051 | 7.1 K to 7.1 K (-1.27 %) |
Mar 20 2018 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 17.88 | 257 | 4,595 | 7,142 | 7.4 K to 7.1 K (-3.47 %) |
Mar 20 2018 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 265 | 0 | 7,399 | 7.1 K to 7.4 K (+3.71 %) |
Mar 20 2018 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 747 | 0 | 7,134 | 6.4 K to 7.1 K (+11.70 %) |
Feb 12 2018 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | A | 0.00 | 48,361 | 0 | 48,361 | |
Feb 12 2018 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | A | 18.61 | 123,288 | 2,294,390 | 123,288 | |
Mar 08 2013 | ACT | Actavis, Inc. | Fridriksdottir Hafrun | Sr VP,Global Generi ... | Grant | A | 0.00 | 1,727 | 0 | 1,727 | 0 to 1.7 K |
Page: 1